Expression and correlation of matrix metalloproteinase-9 and heparanase in patients with breast cancer

Antitumor efficacy of the heparanase inhibitor SST0001 alone and in combination with antiangiogenic agents in the treatment of human pediatric sarcoma models

(2013) G. Cassinelli et al.   BIOCHEMICAL PHARMACOLOGY

Cancer statistics, 2013

(2013) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

The expression and clinical significance of microRNA-1258 and heparanase in human breast cancer

(2013) Dabei Tang et al.   CLINICAL BIOCHEMISTRY

Matrix Metalloproteinase-9 as a Potential Tumor Marker in Breast Cancer

(2013) Durga Prasad Nanda et al.   JOURNAL OF ENVIRONMENTAL PATHOLOGY TOXICOLOGY AND ONCOLOGY

Heparan Sulfate and Heparanase as Modulators of Breast Cancer Progression

(2013) Angélica M. Gomes et al.   Biomed Research International

The association between the preoperative serum levels of lipocalin-2 and matrix metalloproteinase-9 (MMP-9) and prognosis of breast cancer

(2012) Hyuna Sung et al.   BMC CANCER

High expression of CD147 and MMP-9 is correlated with poor prognosis of triple-negative breast cancer (TNBC) patients

(2012) Shu Zhao et al.   MEDICAL ONCOLOGY

Role of serum matrix metalloproteinase-2 and -9 to predict breast cancer progression

(2011) Suprava Patel et al.   CLINICAL BIOCHEMISTRY

Evaluation of heparanase and matrix metalloproteinase-9 in patients with cutaneous malignant melanoma

(2011) Yanhui CHEN et al.   JOURNAL OF DERMATOLOGY

Localization of uPAR and MMP-9 in lipid rafts is critical for migration, invasion and angiogenesis in human breast cancer cells

(2010) Hari Raghu et al.   BMC CANCER

Structure-Function Approach Identifies a COOH-Terminal Domain That Mediates Heparanase Signaling

(2009) L. Fux et al.   CANCER RESEARCH

Prognostic significance of MMP-9 and TIMP-1 serum and tissue expression in breast cancer

(2008) Zheng-Sheng Wu et al.   INTERNATIONAL JOURNAL OF CANCER

Heparanase Stimulation of Protease Expression Implicates It as a Master Regulator of the Aggressive Tumor Phenotype in Myeloma

(2008) Anurag Purushothaman et al.   JOURNAL OF BIOLOGICAL CHEMISTRY